PHARMAGEN, INC. Interest and Debt Expense
PHARMAGEN, INC. reported Interest and Debt Expense of $244.88 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2013-04-01.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestAndDebtExpense · last filed 2013-04-01
- PHARMAGEN, INC. interest and debt expense for the quarter ending 2012-12-31 was $73.16K.
- PHARMAGEN, INC. interest and debt expense for the quarter ending 2012-09-30 was $50.37K.
- PHARMAGEN, INC. interest and debt expense for fiscal 2012 was $244.88K.
| Period end | Interest and Debt Expense 3 month | Interest and Debt Expense 6 month | Interest and Debt Expense 9 month | Interest and Debt Expense 12 month |
|---|---|---|---|---|
| 2012-12-31 | $73.16K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $123.53K derived: sum of 2 quarters · filed 2013-04-01 | $244.88K 10-K · filed 2013-04-01 | |
| 2012-09-30 | $50.37K 10-Q · filed 2012-11-14 | $171.72K 10-Q · filed 2012-11-14 |